[ Price : $8.95]
Complement Therapeutics gains IND clearance to begin human testing of its lead gene therapy, CTx001, in patients with geographic a...[ Price : $8.95]
FDA grants Vivace Therapeutics a fast track designation for its lead cancer drug VT3989, a first-in-class TEAD autopalmitoylation ...[ Price : $8.95]
FDA warns Garland, TX-based Naturich Cosmetique about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA says Trividia Health has recalled 601 blood glucose meters that may have defective LCD displays.[ Price : $8.95]
FDA issues Xspray Pharma a complete response letter on its NDA for Dasynoc (dasatinib) and its use for treating chronic myeloid le...[ Price : $8.95]
A federal judge gives Eli Lilly a partial win in a lawsuit challenging FDAs refusal to classify retatrutide the companys investig...[ Price : $8.95]
AstraZeneca says its investigational drug baxdrostat met the primary endpoint in the Phase 3 Bax24 trial in patients with resistan...[ Price : $8.95]
Thirteen Republican House members call on HHS to lay off the CDER director, Office of Generic Drugs director, and others who were ...